company background image
EAPI logo

Euroapi ENXTPA:EAPI Stock Report

Last Price

€3.41

Market Cap

€322.0m

7D

-5.9%

1Y

-36.3%

Updated

20 Nov, 2024

Data

Company Financials +

Euroapi S.A.

ENXTPA:EAPI Stock Report

Market Cap: €322.0m

EAPI Stock Overview

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. More details

EAPI fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Trading at 81.5% below our estimate of its fair value

Trading at good value compared to peers and industry

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months compared to the French market


Euroapi S.A. Competitors

MedinCell

ENXTPA:MEDCL

€500.3m

Boiron

ENXTPA:BOI

€519.1m

Vetoquinol

ENXTPA:VETO

€933.6m

AB Science

ENXTPA:AB

€53.6m

Price History & Performance

Summary of all time highs, changes and price drops for Euroapi
Historical stock prices
Current Share Price€3.41
52 Week High€7.02
52 Week Low€2.26
Beta0.56
11 Month Change5.24%
3 Month Change-24.80%
1 Year Change-36.31%
33 Year Changen/a
5 Year Changen/a
Change since IPO-74.74%

Recent News & Updates

Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

Oct 04
Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

Recent updates

Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

Oct 04
Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

There's No Escaping Euroapi S.A.'s (EPA:EAPI) Muted Revenues Despite A 32% Share Price Rise

Jul 29
There's No Escaping Euroapi S.A.'s (EPA:EAPI) Muted Revenues Despite A 32% Share Price Rise

Euroapi S.A. (EPA:EAPI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 24
Euroapi S.A. (EPA:EAPI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Euroapi (EPA:EAPI) Seems To Be Using A Lot Of Debt

Apr 10
Euroapi (EPA:EAPI) Seems To Be Using A Lot Of Debt

Little Excitement Around Euroapi S.A.'s (EPA:EAPI) Revenues As Shares Take 31% Pounding

Mar 03
Little Excitement Around Euroapi S.A.'s (EPA:EAPI) Revenues As Shares Take 31% Pounding

Euroapi S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Mar 02
Euroapi S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

A Look At The Fair Value Of Euroapi S.A. (EPA:EAPI)

Dec 21
A Look At The Fair Value Of Euroapi S.A. (EPA:EAPI)

Analysts Are Updating Their Euroapi S.A. (EPA:EAPI) Estimates After Its Half-Yearly Results

Aug 04
Analysts Are Updating Their Euroapi S.A. (EPA:EAPI) Estimates After Its Half-Yearly Results

Is Euroapi S.A. (EPA:EAPI) Trading At A 49% Discount?

Aug 02
Is Euroapi S.A. (EPA:EAPI) Trading At A 49% Discount?

Euroapi S.A.'s (EPA:EAPI) Subdued P/S Might Signal An Opportunity

Jun 16
Euroapi S.A.'s (EPA:EAPI) Subdued P/S Might Signal An Opportunity

An Intrinsic Calculation For Euroapi S.A. (EPA:EAPI) Suggests It's 37% Undervalued

Jan 25
An Intrinsic Calculation For Euroapi S.A. (EPA:EAPI) Suggests It's 37% Undervalued

Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 38% Above Its Share Price

Oct 15
Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 38% Above Its Share Price

Statutory Profit Doesn't Reflect How Good Euroapi's (EPA:EAPI) Earnings Are

Sep 09
Statutory Profit Doesn't Reflect How Good Euroapi's (EPA:EAPI) Earnings Are

Shareholder Returns

EAPIFR PharmaceuticalsFR Market
7D-5.9%-3.4%-0.3%
1Y-36.3%6.2%-3.5%

Return vs Industry: EAPI underperformed the French Pharmaceuticals industry which returned 6.2% over the past year.

Return vs Market: EAPI underperformed the French Market which returned -2.5% over the past year.

Price Volatility

Is EAPI's price volatile compared to industry and market?
EAPI volatility
EAPI Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement4.5%
10% most volatile stocks in FR Market9.2%
10% least volatile stocks in FR Market2.2%

Stable Share Price: EAPI's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: EAPI's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
20203,329Ludwig De Motwww.euroapi.com/en

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.

Euroapi S.A. Fundamentals Summary

How do Euroapi's earnings and revenue compare to its market cap?
EAPI fundamental statistics
Market cap€321.99m
Earnings (TTM)-€287.30m
Revenue (TTM)€971.30m

0.3x

P/S Ratio

-1.1x

P/E Ratio

Is EAPI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EAPI income statement (TTM)
Revenue€971.30m
Cost of Revenue€805.80m
Gross Profit€165.50m
Other Expenses€452.80m
Earnings-€287.30m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 11, 2025

Earnings per share (EPS)-3.02
Gross Margin17.04%
Net Profit Margin-29.58%
Debt/Equity Ratio50.9%

How did EAPI perform over the long term?

See historical performance and comparison